Search alternatives:
ngn decrease » mean decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
n decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
Showing 81 - 100 results of 5,406 for search '(((( 50 ((ngn decrease) OR (nn decrease)) ) OR ( 5 ng decrease ))) OR ( 50 n decrease ))', query time: 1.18s Refine Results
  1. 81
    Quantification and accuracy of average VAF.

    Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 82
    Analytical sensitivity and reproducibility.

    Analytical sensitivity and reproducibility. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 83
    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation.

    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 84
    Schematic overview of the cross-platform study.

    Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 85
    Reference mutations versus background noise across replicates.

    Reference mutations versus background noise across replicates. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 86
    Coverage of reference gene panel by assay A to E for reference samples.

    Coverage of reference gene panel by assay A to E for reference samples. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 87
    Impact of mutation type on VAF quantification performance.

    Impact of mutation type on VAF quantification performance. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 88
    Assay specifications from the vendors.

    Assay specifications from the vendors. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 89
    False positive rate.

    False positive rate. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 90
    Impact of DNA extraction process on depth of coverage.

    Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 91
    Exercise capacity at baseline, pre-lockdown, and post lock down measurements (n = 198).

    Exercise capacity at baseline, pre-lockdown, and post lock down measurements (n = 198). by Feras Haskiah (14204097)

    Published 2022
    Save to List
    Saved in:
  12. 92
    Event-free survival estimate of the pulmonary arterial hypertension cohort based on the HRR1 <18 beats (n = 50) and ≥18 beats (n = 52) after a long follow-up period.

    Event-free survival estimate of the pulmonary arterial hypertension cohort based on the HRR1 <18 beats (n = 50) and ≥18 beats (n = 52) after a long follow-up period. by Camila Farnese Rezende (12666902)

    Published 2022
    Save to List
    Saved in:
  13. 93
    Populations and outcomes modeled in included studies (n = 61).

    Populations and outcomes modeled in included studies (n = 61). by Natalie Riva Smith (13899600)

    Published 2022
    Save to List
    Saved in:
  14. 94
    Screening of either Higher Binding Affinity or Non-affinity scFv against Wild-type or Beta SARS-CoV-2.

    Screening of either Higher Binding Affinity or Non-affinity scFv against Wild-type or Beta SARS-CoV-2. by Ye Yang (297214)

    Published 2023
    Save to List
    Saved in:
  15. 95
    Prevalence of smoking during COVID19 (n = 1844).

    Prevalence of smoking during COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

    Published 2023
    Save to List
    Saved in:
  16. 96
    Sexual symptoms, (N = 73).

    Sexual symptoms, (N = 73). by Wafa Y. Ahmed (20727327)

    Published 2025
    Save to List
    Saved in:
  17. 97
    Purpose of deinfibulation, (N = 73).

    Purpose of deinfibulation, (N = 73). by Wafa Y. Ahmed (20727327)

    Published 2025
    Save to List
    Saved in:
  18. 98
    Measurement of mitochondrial superoxide anion production in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG.

    Measurement of mitochondrial superoxide anion production in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. by Patrick Mordel (17020879)

    Published 2023
    Save to List
    Saved in:
  19. 99
    The relative difference between the target dose of plan S<sub>50</sub> and base plan (n

    The relative difference between the target dose of plan S<sub>50</sub> and base plan (n by Huaqu Zeng (20601563)

    Published 2025
    Save to List
    Saved in:
  20. 100
    Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae

    Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

    Published 2025
    Save to List
    Saved in:

Search Tools: